TrialSexually transmitted infections2014

HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.

M Bradford Guffey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.